Impact of Premenstrual Syndrome and Premenstrual Dysphoric Disorder on Women's Health in Sialkot, Pakistan
Impact of PMS and PMDD on Women's Health
DOI:
https://doi.org/10.61919/jhrr.v4i3.1694Keywords:
Premenstrual Syndrome, Premenstrual Dysphoric Disorder, Women's health, Quality of life, Mental healthAbstract
Background: Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) are common reproductive disorders. Despite their impact on physical and mental health, public awareness and knowledge about these illnesses are limited, particularly in Pakistan.
Objective: This study aims to evaluate the effects of PMS and PMDD on the health and quality of life of women residing in Sialkot, Pakistan.
Methods: A cross-sectional survey was conducted with 422 individuals from the general population of Sialkot. After obtaining their consent, questionnaires were distributed and completed by the participants.
Results: Among the 422 participants, 64% were aware of PMS and PMDD, while 35% were unaware of these conditions. Factors such as age, education level, and gender influenced awareness levels. Additionally, 39% considered these disorders to be life-threatening conditions. The majority of participants had limited knowledge about PMS and PMDD diagnostic procedures and therapies.
Conclusion: The study findings revealed a significant gap in public understanding of PMS and PMDD. Targeted educational programs are essential to raise awareness about these conditions. Addressing these gaps can lead to improved health outcomes and greater support for individuals suffering from these disorders.
Downloads
References
Abdi F, Ozgoli G, Rahnemaie FS. A Systematic Review of the Role of Vitamin D and Calcium in Premenstrual Syndrome. Obstet Gynecol Sci. 2019;62(2):73-86.
Abeje A, Berhanu Z. Premenstrual Syndrome and Factors Associated With It Among Secondary and Preparatory School Students in Debremarkos Town, North-West Ethiopia, 2016. BMC Public Health. 2019;12:1-5.
Abu Alwafa R, Badrasawi M, Haj Hamad R. Prevalence of Premenstrual Syndrome and Its Association With Psychosocial and Lifestyle Variables: A Cross-Sectional Study From Palestine. BMC Womens Health. 2021;21(1):233.
Alshammari E. Magnesium Supplementation for Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Int J Pharm Res. 2021;13(1).
Arab A, Rafie N, Askari G, Taghiabadi M. Beneficial Role of Calcium in Premenstrual Syndrome: A Systematic Review of Current Literature. Int J Prev Med. 2020;11(1):156.
Babapour F, Elyasi F, Shahhosseini Z, Hosseini Tabaghdehi M. The Prevalence of Moderate–Severe Premenstrual Syndrome and Premenstrual Dysphoric Disorder and the Related Factors in High School Students: A Cross-Sectional Study. Neuropsychopharmacol Rep. 2023;43(2):249-254.
Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol. 2015;182(12):1000-1009.
Freeman EW. Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Definitions and Diagnosis. Psychoneuroendocrinology. 2003;28:25-37.
Freeman EW. Therapeutic Management of Premenstrual Syndrome. Expert Opin Pharmacother. 2010;11(17):2879-2889.
Hofmeister S, Bodden S. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician. 2016;94(3):236-240.
Jeong D, Lee H, Kim J. Effects of Sleep Pattern, Duration, and Quality on Premenstrual Syndrome and Primary Dysmenorrhea in Korean High School Girls. BMC Womens Health. 2023;23(1):456.
Kessel B. Premenstrual Syndrome: Advances in Diagnosis and Treatment. Obstet Gynecol Clin North Am. 2000;27(3):625-639.
Lustyk MKB, Gerrish WG, Shaver S, Keys SL. Cognitive Behavioral Therapy for Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review. Arch Womens Ment Health. 2009;12:85-96.
Modzelewski S, Oracz A, Żukow X, Śledzikowka Z, Waszkiewicz N. Premenstrual Syndrome: New Insights Into Etiology and Review of Treatment Methods. Front Psychiatry. 2024;15:1363875.
Mortola JF. Premenstrual Syndrome. Trends Endocrinol Metab. 1996;7(5):184-189.
Nisar N, Zehra N, Haider G, Munir AA, Sohoo NA. Frequency, Intensity, and Impact of Premenstrual Syndrome in Medical Students. J Coll Physicians Surg Pak. 2008;18(8):481-484.
Rajabi F, Rahimi M, Sharbafchizadeh MR, Tarrahi MJ. Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial. Adv Biomed Res. 2020;9(1):60.
Rapkin AJ, Lewis EI. Treatment of Premenstrual Dysphoric Disorder. Womens Health. 2013;9(6):537-556.
Ryu A, Kim TH. Premenstrual Syndrome: A Mini Review. Maturitas. 2015;82(4):436-440.
Sassoon SA, Colrain IM, Baker FC. Personality Disorders in Women With Severe Premenstrual Syndrome. Arch Womens Ment Health. 2011;14:257-264.
Sayehmiri K, Asadi-Samani M, Bahmani M. Effects of Vitamin B6 on Premenstrual Syndrome: A Systematic Review and Meta-Analysis. J Chem Pharm Sci. 2016;9(3):1346-1353.
Steiner M. Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Guidelines for Management. J Psychiatry Neurosci. 2000;25(5):459.
Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Yonkers KA. Expert Guidelines for the Treatment of Severe PMS, PMDD, and Comorbidities: The Role of SSRIs. J Womens Health. 2006;15(1):57-69.
Vichnin M, Freeman EW, Lin H, Hillman J, Bui S. Premenstrual Syndrome (PMS) in Adolescents: Severity and Impairment. J Pediatr Adolesc Gynecol. 2006;19(6):397-402.
Yonkers KA, McCunn KL. Comorbidity of Premenstrual Syndrome and Premenstrual Dysphoric Disorder With Other Psychiatric Conditions. The Premenstrual Disorders: PMS and PMDD. CRC; 2007:49-54.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Fatima Afzal, Sherjeel Adnan, Saima Zahid, Muskan Majeed, Sibgha Imtiaz, Aneeb Ahmad, Tafseer Zahra, Seemab Jannat, Mehak Ali, Ali Zeeshan
This work is licensed under a Creative Commons Attribution 4.0 International License.
